These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 2119247)
41. Systemic therapy of advanced metastatic malignant melanoma with a combination of fibroblast interferon-beta and recombinant interferon-gamma. Kowalzick L; Weyer U; Lange P; Breitbart EW Dermatologica; 1990; 181(4):298-303. PubMed ID: 2127402 [TBL] [Abstract][Full Text] [Related]
42. Recombinant fibroblast interferon and immune interferon for treating chronic hepatitis B virus infection: patients' tolerance and the effect on viral markers. Bissett J; Eisenberg M; Gregory P; Robinson WS; Merigan TC J Infect Dis; 1988 May; 157(5):1076-80. PubMed ID: 3129521 [No Abstract] [Full Text] [Related]
43. [Experimental studies on the amplification of anti-tumor effects using bacterial DNA-treated cancer cells, immunoactivators and interferon]. Kitasato M Nihon Gan Chiryo Gakkai Shi; 1985 Jul; 20(6):1107-16. PubMed ID: 3934297 [No Abstract] [Full Text] [Related]
44. Gamma-interferon: physiology and speculation on its role in medicine. Bonnem EM; Oldham RK J Biol Response Mod; 1987 Jun; 6(3):275-301. PubMed ID: 3110378 [TBL] [Abstract][Full Text] [Related]
45. Type I interferon resistance in a colorectal cancer cell line is associated with a more aggressive phenotype in vivo. Toth CA; Thomas P Br J Cancer; 1992 Mar; 65(3):365-8. PubMed ID: 1558789 [TBL] [Abstract][Full Text] [Related]
46. [Current status of the problem of interferon (theoretical and practical aspects)]. Kuznetsov VP Antibiot Khimioter; 1989 Sep; 34(9):646-52. PubMed ID: 2514629 [TBL] [Abstract][Full Text] [Related]
47. Interferon treatment of renal cell carcinoma. Current status and future prospects. Krown SE Cancer; 1987 Feb; 59(3 Suppl):647-51. PubMed ID: 10822464 [TBL] [Abstract][Full Text] [Related]
48. The effects of alpha and gamma interferons on human lung cancer cells grown in vitro or as xenografts in nude mice. Twentyman PR; Workman P; Wright KA; Bleehen NM Br J Cancer; 1985 Jul; 52(1):21-9. PubMed ID: 3925974 [TBL] [Abstract][Full Text] [Related]
49. The potency of interferon-alpha 2 and interferon-gamma in a combination therapy of dendritic keratitis. A controlled clinical study. Sundmacher R; Mattes A; Neumann-Haefelin D; Adolf G; Kruss B Curr Eye Res; 1987 Jan; 6(1):273-6. PubMed ID: 3030650 [TBL] [Abstract][Full Text] [Related]
50. Rapid response to 2'-deoxycoformycin in advanced hairy cell leukemia after failure of interferons alpha and gamma. Lembersky BC; Ratain MJ; Westbrook C; Golomb HM Am J Hematol; 1988 Jan; 27(1):60-2. PubMed ID: 3128105 [TBL] [Abstract][Full Text] [Related]
51. [Clinical studies on interferon in cancer therapy in Japan]. Ohno R Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1194-202. PubMed ID: 2437862 [TBL] [Abstract][Full Text] [Related]
52. A phase I-II trial of the combination of recombinant leukocyte A interferon and recombinant human interferon-gamma in patients with metastatic malignant melanoma. Creagan ET; Loprinzi CL; Ahmann DL; Schaid DJ Cancer; 1988 Dec; 62(12):2472-4. PubMed ID: 3142675 [TBL] [Abstract][Full Text] [Related]
53. [Current problems on interferon research]. Kishida T Gan To Kagaku Ryoho; 1984 Jan; 11(1):10-5. PubMed ID: 6198963 [TBL] [Abstract][Full Text] [Related]
54. [Interferon (IFN) therapy (recombinant IFN-alpha-2C or recombinant IFN-gamma) in metastasized hypernephroma]. Kuzmits R; Scheithauer W; Ludwig H; Flener R Acta Med Austriaca; 1985; 12(5):129-34. PubMed ID: 3938590 [TBL] [Abstract][Full Text] [Related]
55. [Phase II study of natural interferon-gamma. Natural Interferon-gamma Cooperative Study Group]. Furue H Gan To Kagaku Ryoho; 1987 Aug; 14(8):2542-7. PubMed ID: 3113342 [TBL] [Abstract][Full Text] [Related]
56. Effect of interferons (rIFN-alpha 2, rIFN-gamma) on DNA-synthesis and HLA-DR expression in psoriasis. Schulze HJ; Mahrle G Arch Dermatol Res; 1986; 278(5):416-8. PubMed ID: 3092749 [No Abstract] [Full Text] [Related]
57. Clinical study with recombinant interferon gamma versus interferon alpha-2c in patients with condylomata acuminata. Reichel RP; Fitz R; Neumann R; Pohl-Markl H; Pichler E; Hoffer Z; Budiman R Int J STD AIDS; 1992; 3(5):350-4. PubMed ID: 1391062 [TBL] [Abstract][Full Text] [Related]
58. Evidence for the elevation of serum carcinoembryonic antigen and tumor-associated glycoprotein-72 levels in patients administered interferons. Greiner JW; Guadagni F; Goldstein D; Borden EC; Ritts RE; Witt P; LoBuglio AF; Saleh MN; Schlom J Cancer Res; 1991 Aug; 51(16):4155-63. PubMed ID: 1907881 [TBL] [Abstract][Full Text] [Related]
59. Differential sensitivity of renal cell carcinoma xenografts towards therapy with interferon-alpha, interferon-gamma, tumor necrosis factor and their combinations. Beniers AJ; van Moorselaar RJ; Peelen WP; Debruyne FM; Schalken JA Urol Res; 1991; 19(2):91-8. PubMed ID: 1906659 [TBL] [Abstract][Full Text] [Related]